Biology

Improving animal models in Alzheimer’s disease research 1:59
Improving animal models in Alzheimer’s disease research
Michael Heneka
Inflammation in Alzheimer’s disease: what we know and what’s to come 1:03
Inflammation in Alzheimer’s disease: what we know and what’s to come
Michael Heneka
Why narcolepsy should not be considered an autoimmune disorder 7:19
Why narcolepsy should not be considered an autoimmune disorder
Angela Vincent
Dementia and stress: the challenges 1:01
Dementia and stress: the challenges
Luiza Spiru
Studying deep brain stimulation: developing portable devices for rodents 1:56
Studying deep brain stimulation: developing portable devices for rodents
Abdelhamid Benazzouz
Dementia, stress and the molecular age of the brain 3:08
Dementia, stress and the molecular age of the brain
Luiza Spiru
Defining Alzheimer’s disease: clinical or biological 2:22
Defining Alzheimer’s disease: clinical or biological
Bart De Strooper
Inequality in the workplace impacts everyone involved 3:09
Inequality in the workplace impacts everyone involved
Tali Sharot
Cross neurodegenerative disease genetic analysis: similarities and differences 2:20
Cross neurodegenerative disease genetic analysis: similarities and differences
John Hardy
Potential environmental triggers of sporadic ALS 2:32
Potential environmental triggers of sporadic ALS
Peter Spencer
The reconstructed cohort design: tracking rare neurodegenerative diseases 4:40
The reconstructed cohort design: tracking rare neurodegenerative diseases
Giancarlo Logroscino
Evidence supporting narcolepsy as an autoimmune disorder 7:01
Evidence supporting narcolepsy as an autoimmune disorder
Jacek Losy
Potential toxins causing sporadic ALS: nitrosamines and hydrazines 2:40
Potential toxins causing sporadic ALS: nitrosamines and hydrazines
Peter Spencer
The benefits of GWAS in understanding Alzheimer’s disease 2:00
The benefits of GWAS in understanding Alzheimer’s disease
John Hardy
Why we form beliefs that are inaccurate 7:05
Why we form beliefs that are inaccurate
Tali Sharot
Therapeutic development in Alzheimer’s disease and the lack of funding 2:02
Therapeutic development in Alzheimer’s disease and the lack of funding
Bart De Strooper
The content of VJNeurology is intended for healthcare professionals